search
Back to results

Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer (APACHE-4)

Primary Purpose

Cervical Cancer Screening, Cervical Cancer

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Self-sampling kit sent at home
Self-sampling kit sent at home + SMS reminder
Letter offering a self-sampling kit "on request"+ SMS reminder
SMS offering a self-sampling kit "on request"+ SMS reminder
Sponsored by
University Hospital, Tours
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Cervical Cancer Screening focused on measuring vaginal, self-sampling, cervical cancer screening, Papillomavirus, HPV, High Risk Human papillomavirus Infection, pap smear

Eligibility Criteria

30 Years - 66 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • women from 30 to 66 years old
  • women living in french territorial division 37 ("Indre-et-Loire")
  • women with a mobile phone in database
  • women who do not perform a pap smear in the last 4 years
  • women who do not answer to a first "invitation" letter to perform a pap smear

Exclusion Criteria:

  • STOP SMS
  • HPV cervical pathology during treatment
  • Hysterectomy including cervix

Sites / Locations

  • Crcdc-Cvl

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Experimental

Experimental

Experimental

Arm Label

Self-sampling kit sent at home

Self-sampling kit sent at home + SMS reminder

Letter offering a self-sampling kit "on request"+ SMS reminder

SMS offering a self-sampling kit "on request"+ SMS reminder

Arm Description

Sending of a vaginal self-sampling kit at home

Sending of a vaginal self-sampling kit at home + a SMS reminder is sent if the woman do not (in 2 months) : perform a pap smear or send her vaginal self-sample to the laboratory or contact the screening center to inform to an exclusion reason

Sending of letter offering a vaginal self-sampling kit. Women can ask for this kit on line, on our website or by calling us. If they do ask for the kit, one kit is sending to their home. For these women, a SMS reminder is sent if the woman do not (in 2 months) : perform a pap smear or send her vaginal self-sample to the laboratory or contact the screening center to inform to an exclusion reason

Sending of SMS offering a vaginal self-sampling kit. Women can ask for this kit on line, on our website or by calling us. If they do ask for the kit, one kit is sending to their home. For these women, a SMS reminder is sent if the woman do not (in 2 months) : perform a pap smear or send her vaginal self-sample to the laboratory or contact the screening center to inform to an exclusion reason

Outcomes

Primary Outcome Measures

Participation / no participation to complete cervical cancer screening
Complete cervical cancer screening is defined as one of the followings : perform a pap smear perform a vaginal self-sampling with negative HR-HPV test perform a vaginal self-sampling with noninterpretable HR-HPV test result followed by a control pap smear (nine-month extension to do the pap smear after the sending of the HPV result) perform a vaginal self-sampling with positive HR-HPV test result followed by a control pap smear (nine-month extension to do the pap smear after the sending of the HPV result)

Secondary Outcome Measures

Full Information

First Posted
February 26, 2019
Last Updated
October 28, 2021
Sponsor
University Hospital, Tours
Collaborators
Centre Régional de Coordination des Dépistages des Cancers - Centre-Val de Loire, Centre d'Investigation Clinique-P1415, TOURS
search

1. Study Identification

Unique Protocol Identification Number
NCT03856684
Brief Title
Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer
Acronym
APACHE-4
Official Title
Randomized Trial Evaluating Women's Behavior Not Participating in Cervical Cancer Screening Facing Three Strategies for Optimizing Home Sending by Post of Vaginal Self-sampling Kit
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
February 11, 2020 (Actual)
Primary Completion Date
July 14, 2021 (Actual)
Study Completion Date
October 20, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Tours
Collaborators
Centre Régional de Coordination des Dépistages des Cancers - Centre-Val de Loire, Centre d'Investigation Clinique-P1415, TOURS

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Despite the existence of an effective screening test (pap smear), cervical cancer is, every year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in 10 women are not screened or not often enough (nearly 7 millions women). It is therefore necessary to develop new strategies to reach these women. The etiological factor of this cancer is persistent infection with High-Risk Human PapillomaVirus (HR-HPV). Thereby, HPV-based tests could be alternative screening tests. Vaginal self-sampling with HR-HPV test is simpler and less intrusive than the pap smear. It has been shown that sending vaginal self-sampling kit (with HPV test) to unscreened women's home is a powerful means to increase the participation rate of cervical cancer screening. It seems interesting to explore methods to increase the efficiency of this strategy by optimizing the ratio of the number of kits used compared to the number of kits sent. Two approaches will be tested: a system "available on request" of the kit and / or the addition of an SMS (Short Message Service) reminder.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Cancer Screening, Cervical Cancer
Keywords
vaginal, self-sampling, cervical cancer screening, Papillomavirus, HPV, High Risk Human papillomavirus Infection, pap smear

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
10400 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Self-sampling kit sent at home
Arm Type
Active Comparator
Arm Description
Sending of a vaginal self-sampling kit at home
Arm Title
Self-sampling kit sent at home + SMS reminder
Arm Type
Experimental
Arm Description
Sending of a vaginal self-sampling kit at home + a SMS reminder is sent if the woman do not (in 2 months) : perform a pap smear or send her vaginal self-sample to the laboratory or contact the screening center to inform to an exclusion reason
Arm Title
Letter offering a self-sampling kit "on request"+ SMS reminder
Arm Type
Experimental
Arm Description
Sending of letter offering a vaginal self-sampling kit. Women can ask for this kit on line, on our website or by calling us. If they do ask for the kit, one kit is sending to their home. For these women, a SMS reminder is sent if the woman do not (in 2 months) : perform a pap smear or send her vaginal self-sample to the laboratory or contact the screening center to inform to an exclusion reason
Arm Title
SMS offering a self-sampling kit "on request"+ SMS reminder
Arm Type
Experimental
Arm Description
Sending of SMS offering a vaginal self-sampling kit. Women can ask for this kit on line, on our website or by calling us. If they do ask for the kit, one kit is sending to their home. For these women, a SMS reminder is sent if the woman do not (in 2 months) : perform a pap smear or send her vaginal self-sample to the laboratory or contact the screening center to inform to an exclusion reason
Intervention Type
Behavioral
Intervention Name(s)
Self-sampling kit sent at home
Intervention Description
Selected women receive a mail inviting them either to perform a vaginal self sampling at their home (with the kit provided) or to perform a pap smear. When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.
Intervention Type
Behavioral
Intervention Name(s)
Self-sampling kit sent at home + SMS reminder
Intervention Description
Selected women receive a mail inviting them either to perform a vaginal self sampling at their home (with the kit provided) or to perform a pap smear. After 2 months without "return", a SMS reminder about the available self-sampling kit is sent to the woman. We call "return" : the receipt of the vaginal self-sample at the laboratory the performance of a pap smear Information about recent screening test or a cervical screening exclusion reason When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.
Intervention Type
Behavioral
Intervention Name(s)
Letter offering a self-sampling kit "on request"+ SMS reminder
Intervention Description
Selected women receive a mail inviting them either to perform a vaginal self sampling at their home (kit provided on request) or to perform a pap smear. Women are invited to ask the kit online, on our website. For the women who ask the kit, after 2 months without "return", a SMS reminder about the available self-sampling kit is sent to the woman. We call "return" : the receipt of the vaginal self-sample at the laboratory the performance of a pap smear Information about recent screening test or a cervical screening exclusion reason When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.
Intervention Type
Behavioral
Intervention Name(s)
SMS offering a self-sampling kit "on request"+ SMS reminder
Intervention Description
Selected women receive a SMS inviting them to ask a vaginal self sampling kit to perform a sample at home and send it to a laboratory (kit provided on request). Women are invited to ask the kit by answering "1" by SMS. For the women who ask the kit, after 2 months without "return", a SMS reminder about the available self-sampling kit is sent to the woman. We call "return" : the receipt of the vaginal self-sample at the laboratory the performance of a pap smear Information about recent screening test or a cervical screening exclusion reason When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.
Primary Outcome Measure Information:
Title
Participation / no participation to complete cervical cancer screening
Description
Complete cervical cancer screening is defined as one of the followings : perform a pap smear perform a vaginal self-sampling with negative HR-HPV test perform a vaginal self-sampling with noninterpretable HR-HPV test result followed by a control pap smear (nine-month extension to do the pap smear after the sending of the HPV result) perform a vaginal self-sampling with positive HR-HPV test result followed by a control pap smear (nine-month extension to do the pap smear after the sending of the HPV result)
Time Frame
9 months after postal mail (with or without the kit) or SMS

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
66 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: women from 30 to 66 years old women living in french territorial division 37 ("Indre-et-Loire") women with a mobile phone in database women who do not perform a pap smear in the last 4 years women who do not answer to a first "invitation" letter to perform a pap smear Exclusion Criteria: STOP SMS HPV cervical pathology during treatment Hysterectomy including cervix
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Julie BOYARD, MSc
Organizational Affiliation
University Hospital of TOURS
Official's Role
Principal Investigator
Facility Information:
Facility Name
Crcdc-Cvl
City
Tours
ZIP/Postal Code
37044
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer

We'll reach out to this number within 24 hrs